Biogen, Inc. (BIIB)
178.22
-2.22
(-1.23%)
USD |
NASDAQ |
Dec 09, 15:24
Biogen Price: 178.28 for Dec. 9, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 317.11 |
| Eli Lilly & Co. | 987.00 |
| Merck & Co., Inc. | 97.25 |
| Pfizer Inc. | 25.44 |
| Stoke Therapeutics, Inc. | 30.99 |
Price Related Metrics
| PE Ratio | 16.25 |
| PS Ratio | 2.697 |
| Price to Book Value | 1.436 |
| Price to Free Cash Flow | 11.55 |
| Earnings Yield | 6.15% |
| Market Cap | 26.15B |
| Operating PE Ratio | 10.71 |
| Normalized PE Ratio | 14.41 |